Articles written by: Harry Brown

Navidea Biopharmaceuticals Inc (NAVB) and Realm Therapeutics Plc (NASDAQ:RLM) Contrasting side by side

We are comparing Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) and Realm Therapeutics Plc (NASDAQ:RLM) on their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. They both are Biotechnology companies, competing one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Navidea Biopharmaceuticals Inc 1.45M […]

MSG Networks Inc. (MSGN)’s Financial Results Comparing With Lions Gate Entertainment Corp. (NYSE:LGF.B)

Both MSG Networks Inc. (NYSE:MSGN) and Lions Gate Entertainment Corp. (NYSE:LGF.B) compete on a level playing field in the Entertainment – Diversified industry. We will evaluate their performance with regards to profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income […]

Comparison of Mesoblast Limited (MESO) and Mustang Bio Inc. (NASDAQ:MBIO)

This is a contrast between Mesoblast Limited (NASDAQ:MESO) and Mustang Bio Inc. (NASDAQ:MBIO) based on their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparing of Aeterna Zentaris Inc. (AEZS) and OvaScience Inc. (:)

This is therefore a contrasting of the profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation in Aeterna Zentaris Inc. (NASDAQ:AEZS) and OvaScience Inc. (:). The two are both Biotechnology companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Rexahn Pharmaceuticals Inc. (RNN)’s Financial Results Comparing With Gritstone Oncology Inc. (NASDAQ:GRTS)

Rexahn Pharmaceuticals Inc. (NYSEAMERICAN:RNN) and Gritstone Oncology Inc. (NASDAQ:GRTS) are two firms in the Biotechnology that compete against each other. Below is a comparison of their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Advaxis Inc. (ADXS) and MacroGenics Inc. (NASDAQ:MGNX) Comparison side by side

We will be contrasting the differences between Advaxis Inc. (NASDAQ:ADXS) and MacroGenics Inc. (NASDAQ:MGNX) as far as dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation are concerned. The two businesses are rivals in the Biotechnology industry. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Lattice Semiconductor Corporation (LSCC)’s Financial Results Comparing With JinkoSolar Holding Co. Ltd. (NYSE:JKS)

Lattice Semiconductor Corporation (NASDAQ:LSCC) and JinkoSolar Holding Co. Ltd. (NYSE:JKS) have been rivals in the Semiconductor – Specialized for quite some time. Below is a review of each business including various aspects such as profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales […]

Comparison of Vaxart Inc. (VXRT) and Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

As Biotechnology companies, Vaxart Inc. (NASDAQ:VXRT) and Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) are our subject to contrast. And more specifically their institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vaxart Inc. 4.16M 3.28 18.35M -89.00 […]

Hologic Inc. (HOLX)’s Financial Results Comparing With Valeritas Holdings Inc. (NASDAQ:VLRX)

Both Hologic Inc. (NASDAQ:HOLX) and Valeritas Holdings Inc. (NASDAQ:VLRX) compete on a level playing field in the Medical Instruments & Supplies industry. We will evaluate their performance with regards to analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]

Leap Therapeutics Inc. (LPTX)’s Financial Results Comparing With Immune Design Corp. (NASDAQ:IMDZ)

Leap Therapeutics Inc. (NASDAQ:LPTX) and Immune Design Corp. (NASDAQ:IMDZ), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation of the two firms. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income […]